Study sheds new light on the heterogeneity of type 2 diabetes

A landmark study by the German Diabetes Center (DDZ), published in The Lancet Diabetes & Endocrinology, sheds new light on the heterogeneity of type 2 diabetes.

Pα+ Psychedelic Bulletin #174: Psilocybin Outperforms Escitalopram After 6 Months… or Does It? Survey Results Reveal Healthcare Practitioner Attitudes to Psychedelics; and more… – Psychedelic Alpha

In this Issue Six-Month Follow-Up Data Shows Psilocybin Outperforms Escitalopram… or Does It? Survey Reveals Healthcare Practitioner Attitudes to Psychedelics MIND Foundation Plots 700-Patient Psilocybin

September 27, 2024

Most Appendicitis Patients See Good Long-Term Outcomes With Conservative Tx

Data on long-term outcomes with antibiotics for appendicitis show that most patients will not experience a recurrence, reported researchers who followed up on patients from

August 11, 2023

Poor Neighborhood, More Than Race, Predicts Greater Lupus Skin Severity

People with discoid lupus erythematosus (DLE) living in areas marked by poverty tended to have more severe manifestations, a study in Philadelphia found, whereas associations

July 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.